These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 5005231)

  • 1. [Effect of a protease inhibitor on bacterial multiplication].
    Gastaldi G; Mattiello A
    Pathologica; 1971; 63(923):223-31. PubMed ID: 5005231
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of a protease inhibitor on in vitro stability of intact parathyroid hormone.
    Anderson NR; Nicholas J; Holland MR; Gama R
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):188-90. PubMed ID: 12662411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis and reaction behavior of localized angiotensinase (N) in the juxtaglomerular apparatus of the rat kidney].
    Dahlheim H
    Pflugers Arch; 1972; 332():Suppl 332:R27. PubMed ID: 4340715
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of an insulin-like growth factor binding protein-5 protease produced by rat articular chondrocytes and a neuroblastoma cell line.
    Matsumoto T; Gargosky SE; Kelley K; Rosenfeld RG
    Growth Regul; 1996 Sep; 6(3):185-90. PubMed ID: 8894652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protective effect of a protease inhibitor "Aprotinin" on acute ischemic myocardium].
    Tanaka H; Okamura T; Suzuki T; Sunamori M; Suzuki A
    Rinsho Kyobu Geka; 1984 Sep; 4(5):544-9. PubMed ID: 6084298
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of protease inhibitors of the organism, especially bovine aprotinin, on the production of virulent hog cholera virus in tissue cultures.
    Korn G; Matthaeus W
    Dtsch Tierarztl Wochenschr; 1994 May; 101(5):204-6. PubMed ID: 7516855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
    Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A
    Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of the protease inhibitor aprotinin on tumor invasion of three cell lines in vitro.
    Prange E; Schroyens W; Pralle H
    Clin Exp Metastasis; 1988; 6(2):107-13. PubMed ID: 2449988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the cytotoxic effect of Clostridium histolyticum culture supernatant on HeLa cells in the presence of protease inhibitors.
    Jóźwiak J; Komar A; Jankowska E; Martirosian G
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):137-42. PubMed ID: 16051065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of protease inhibitor on the course of experimental hemolytic shock following blood transfusion in cat].
    Dorobisz T; Fal W; Olearczyk J; Palider S; Samplawska B
    Pol Tyg Lek; 1969 Apr; 24(15):554-6. PubMed ID: 5306554
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification and isolation of the bactericidal domains in the proteinase inhibitor aprotinin.
    Pellegrini A; Thomas U; Bramaz N; Klauser S; Hunziker P; von Fellenberg R
    Biochem Biophys Res Commun; 1996 May; 222(2):559-65. PubMed ID: 8670244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CU-2010--a novel small molecule protease inhibitor with antifibrinolytic and anticoagulant properties.
    Dietrich W; Nicklisch S; Koster A; Spannagl M; Giersiefen H; van de Locht A
    Anesthesiology; 2009 Jan; 110(1):123-30. PubMed ID: 19104179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of a protease inhibitor on hemolytic shock from incompatible blood in rabbits. Experimental research].
    Laurentaci G; Monosi V
    Osp Ital Chir; 1967 Sep; 17(3):247-73. PubMed ID: 5306328
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of some protease inhibitors on phagocytosis.
    Grzybek-Hryncewicz K; Ladosz J; Slopek S
    Arch Immunol Ther Exp (Warsz); 1970; 18(4):442-50. PubMed ID: 5312277
    [No Abstract]   [Full Text] [Related]  

  • 15. Aprotinin: mechanism of action and therapeutical uses.
    Fussi F
    Boll Chim Farm; 1980 Nov; 119(11):631-46. PubMed ID: 6164378
    [No Abstract]   [Full Text] [Related]  

  • 16. Autodisplay of the protease inhibitor aprotinin in Escherichia coli.
    Jose J; Zangen D
    Biochem Biophys Res Commun; 2005 Aug; 333(4):1218-26. PubMed ID: 15979569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
    Kuyvenhoven JP; Molenaar IQ; Verspaget HW; Veldman MG; Palareti G; Legnani C; Moolenburgh SE; Terpstra OT; Lamers CB; van Hoek B; Porte RJ
    Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Action of some proteinase inhibitors on cathepsins in old and young rats].
    Torboli A
    Boll Soc Ital Biol Sper; 1970 Oct; 46(20):845-7. PubMed ID: 5314602
    [No Abstract]   [Full Text] [Related]  

  • 19. The revival of micro-organisms sublethally injured by chemical inhibitors.
    Gilbert P
    Soc Appl Bacteriol Symp Ser; 1984; (12):175-97. PubMed ID: 6208618
    [No Abstract]   [Full Text] [Related]  

  • 20. [Protease inhibitors and wound healing. Results of an double-blind study].
    Gierhake FW; Grabow L; Spitzer G; Müller C; Braun R; Hessler C; Orth HD; Skibbe G; Zimmermann K
    Chirurg; 1971 Aug; 42(8):360-3. PubMed ID: 5315262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.